Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
As a multifactorial and multiorgan syndrome, cancer cachexia is associated with decreased tolerance to antitumor treatments and increased morbidity and mortality rates. The current approaches for the treatment of this syndrome are not always effective and well established. Drug repurposing or reposi...
Saved in:
Main Authors: | Joana M. O. Santos (Author), Alexandra C. Costa (Author), Tânia R. Dias (Author), Setareh Satari (Author), Maria Paula Costa e Silva (Author), Rui M. Gil da Costa (Author), Rui Medeiros (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
by: Sara Peixoto da Silva, et al.
Published: (2020) -
Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
by: Filipa Moreira-Silva, et al.
Published: (2020) -
Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023) -
Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates
by: Yani Berckmans, et al.
Published: (2023) -
A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes.
by: Brendan D Galvin, et al.
Published: (2014)